Significant interaction between testosterone recovery (TR) and biochemical progression-free survival (BPFS) in intermediate and high-risk patients with prostate cancer treated with radiation therapy (RT) and androgen deprivation therapy (ADT)

被引：0
|
作者：
Shasha, D.
Nabhani, T.
Rauth, S. J.
Salant, R.
Harrison, L. B.
机构：
[1] Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, New York, NY 10003 USA
[2] SUNY Hlth Sci Ctr, Dept Radiat Oncol, Brooklyn, NY USA
[3] Beth Israel Deaconess Med Ctr, Dept Urol, New York, NY 10003 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.202
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
202
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Evaluation of biochemical recurrence in patients with high-risk prostate cancer treated with radical prostatectomy and radiotherapy plus androgen deprivation therapy
    Yamamoto, Yutaka
    Kiba, Keisuke
    Yoshikawa, Motokiyo
    Hirayama, Akihide
    Kunikata, Seiji
    Uemura, Hirotsugu
    RESEARCH AND REPORTS IN UROLOGY, 2016, 8 : 225 - 231
  • [22] Androgen Deprivation Therapy: A Survival Benefit or Detriment in Men With High-Risk Prostate Cancer?
    Fang, L. Christine
    Merrick, Gregory S.
    Wallner, Kent E.
    ONCOLOGY-NEW YORK, 2010, 24 (09): : 790 - 797
  • [23] Biochemical Progression-Free Survival (BPFS) for Gleason Score (GS) 7 Prostate Adenocarcinoma Treated With External Beam Radiation (RT) ± Prostate Seed Implant (SI)
    Nabhani, T.
    Mourad, W. F.
    Patel, S.
    Katsoulakis, E.
    Lukens, J. N.
    Gamez, M.
    Patel, R.
    Concert, C.
    Ryniak, M.
    Shourbaji, R. A.
    Shah, N.
    Santoro, J.
    Ambrose, R.
    Dolan, J.
    Woode, R.
    Dinlenc, C.
    Goluboff, E.
    Salant, R.
    Harrison, L. B.
    Shasha, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S428 - S428
  • [24] Testosterone nadir and PSA recurrence-free survival in men with intermediate and high-risk localized prostate cancer undergoing definitive radiotherapy and androgen deprivation therapy.
    Alex, Bryant
    Mckay, Rana R.
    Kader, A. Karim
    Parsons, J. Kellogg
    Einck, John Paul
    Kane, Christopher J.
    Mundt, Arno James
    Murphy, James Don
    Rose, Brent Shane
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [25] Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolix
    Campbell, Patrick
    Gebrael, Georges
    Narang, Arshit
    Chehade, Chadi Hage
    Thomas, Vinay Mathew
    Fortuna, Gliceida Galarza
    Sayegh, Nicolas
    Tripathi, Nishita
    Tandar, Clara
    Dal, Emre
    Li, Haoran
    Swami, Umang
    Agarwal, Neeraj
    Maughan, Benjamin L.
    THERAPEUTIC ADVANCES IN UROLOGY, 2024, 16
  • [26] Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?
    Takagi, M.
    Demizu, Y.
    Fuwa, N.
    Sulaiman, N. S.
    Jin, D.
    Terashima, K.
    Fujii, O.
    Nagano, F.
    Waki, T.
    Mima, M.
    Niwa, Y.
    Katsui, K.
    Murakami, M.
    Okimoto, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E263 - E263
  • [27] A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer
    Hamid, Muhammad
    Heilbrun, Lance K.
    Maier, Jordan
    Devisetty, Kiran
    Connolly, Irene
    Kaufman, Isaac
    Dobson, Kimberlee
    Herroon, Mackenzie K.
    Smith, Daryn
    Sampson, Sandra
    Podgorski, Izabela
    Heath, Elisabeth I.
    ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (04)
  • [28] Whole-Pelvic Versus Prostate-Only Radiation Therapy in Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Androgen Deprivation Therapy and Brachytherapy Boost
    Yang, D. D.
    Mahal, B. A.
    Muralidhar, V.
    Martin, N. E.
    King, M.
    Mouw, K.
    Nguyen, P. L.
    Orio, P. F., III
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E150 - E151
  • [29] Intermediate- to high-risk prostate cancer patient treated with radiation therapy
    Raben, David
    Lucia, Scott
    Glode, Michael
    Crawford, E. David
    Kavanagh, Brian
    Raben, Adam
    Ayres, Jennifer
    ONCOLOGY-NEW YORK, 2004, 18 (09): : 1105 - 1110
  • [30] Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy
    Bao, Bo-Ying
    Pao, Jiunn-Bey
    Huang, Chun-Nung
    Pu, Yeong-Shiau
    Chang, Ta-Yuan
    Lan, Yu-Hsuan
    Lu, Te-Ling
    Lee, Hong-Zin
    Chen, Lu-Min
    Ting, Wen-Chien
    Hsieh, Chi-Jeng
    Huang, Shu-Pin
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (04) : 876 - 884
12345